nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydralazine—RYR2—myometrium—ovarian cancer	0.0304	0.0834	CbGeAlD
Hydralazine—CYP3A4—Topotecan—ovarian cancer	0.0292	0.354	CbGbCtD
Hydralazine—CYP3A4—Vinorelbine—ovarian cancer	0.0206	0.249	CbGbCtD
Hydralazine—RYR2—uterus—ovarian cancer	0.0197	0.0541	CbGeAlD
Hydralazine—AOC3—myometrium—ovarian cancer	0.0183	0.0502	CbGeAlD
Hydralazine—RYR2—female reproductive system—ovarian cancer	0.0177	0.0486	CbGeAlD
Hydralazine—RYR2—female gonad—ovarian cancer	0.0161	0.0442	CbGeAlD
Hydralazine—RYR2—vagina—ovarian cancer	0.016	0.044	CbGeAlD
Hydralazine—P4HA1—myometrium—ovarian cancer	0.0146	0.0401	CbGeAlD
Hydralazine—CYP3A4—Paclitaxel—ovarian cancer	0.0144	0.175	CbGbCtD
Hydralazine—RYR2—testis—ovarian cancer	0.0143	0.0392	CbGeAlD
Hydralazine—AOC3—uterine cervix—ovarian cancer	0.0143	0.0391	CbGeAlD
Hydralazine—AOC3—decidua—ovarian cancer	0.0136	0.0372	CbGeAlD
Hydralazine—AOC3—endometrium—ovarian cancer	0.0129	0.0353	CbGeAlD
Hydralazine—AOC3—gonad—ovarian cancer	0.012	0.0328	CbGeAlD
Hydralazine—AOC3—uterus—ovarian cancer	0.0119	0.0326	CbGeAlD
Hydralazine—P4HA1—uterine cervix—ovarian cancer	0.0114	0.0312	CbGeAlD
Hydralazine—P4HA1—decidua—ovarian cancer	0.0109	0.0298	CbGeAlD
Hydralazine—AOC3—female reproductive system—ovarian cancer	0.0107	0.0293	CbGeAlD
Hydralazine—CYP3A4—Docetaxel—ovarian cancer	0.0104	0.127	CbGbCtD
Hydralazine—P4HA1—endometrium—ovarian cancer	0.0103	0.0283	CbGeAlD
Hydralazine—AOC3—bone marrow—ovarian cancer	0.0101	0.0276	CbGeAlD
Hydralazine—AOC3—female gonad—ovarian cancer	0.00972	0.0266	CbGeAlD
Hydralazine—AOC3—vagina—ovarian cancer	0.00966	0.0265	CbGeAlD
Hydralazine—P4HA1—gonad—ovarian cancer	0.00956	0.0262	CbGeAlD
Hydralazine—P4HA1—uterus—ovarian cancer	0.0095	0.026	CbGeAlD
Hydralazine—AOC3—testis—ovarian cancer	0.00862	0.0236	CbGeAlD
Hydralazine—P4HA1—female reproductive system—ovarian cancer	0.00854	0.0234	CbGeAlD
Hydralazine—P4HA1—bone marrow—ovarian cancer	0.00806	0.0221	CbGeAlD
Hydralazine—CYP3A4—Doxorubicin—ovarian cancer	0.00779	0.0945	CbGbCtD
Hydralazine—P4HA1—female gonad—ovarian cancer	0.00777	0.0213	CbGeAlD
Hydralazine—P4HA1—vagina—ovarian cancer	0.00772	0.0212	CbGeAlD
Hydralazine—P4HA1—testis—ovarian cancer	0.00689	0.0189	CbGeAlD
Hydralazine—AOC3—lymph node—ovarian cancer	0.00625	0.0171	CbGeAlD
Hydralazine—P4HA1—lymph node—ovarian cancer	0.005	0.0137	CbGeAlD
Hydralazine—CYP3A4—female reproductive system—ovarian cancer	0.00226	0.0062	CbGeAlD
Hydralazine—Conjunctivitis—Paclitaxel—ovarian cancer	0.00134	0.00242	CcSEcCtD
Hydralazine—Dyspnoea—Melphalan—ovarian cancer	0.00133	0.00241	CcSEcCtD
Hydralazine—Decreased appetite—Topotecan—ovarian cancer	0.00132	0.0024	CcSEcCtD
Hydralazine—Gastrointestinal disorder—Topotecan—ovarian cancer	0.00132	0.00238	CcSEcCtD
Hydralazine—Dyspepsia—Melphalan—ovarian cancer	0.00131	0.00238	CcSEcCtD
Hydralazine—Haematuria—Paclitaxel—ovarian cancer	0.00131	0.00237	CcSEcCtD
Hydralazine—Constipation—Topotecan—ovarian cancer	0.0013	0.00236	CcSEcCtD
Hydralazine—Decreased appetite—Melphalan—ovarian cancer	0.0013	0.00235	CcSEcCtD
Hydralazine—Gastrointestinal disorder—Melphalan—ovarian cancer	0.00129	0.00233	CcSEcCtD
Hydralazine—Thrombocytopenia—Vinorelbine—ovarian cancer	0.00128	0.00231	CcSEcCtD
Hydralazine—Angina pectoris—Docetaxel—ovarian cancer	0.00127	0.0023	CcSEcCtD
Hydralazine—Tachycardia—Vinorelbine—ovarian cancer	0.00127	0.0023	CcSEcCtD
Hydralazine—Hypersensitivity—Chlorambucil—ovarian cancer	0.00126	0.00228	CcSEcCtD
Hydralazine—Feeling abnormal—Topotecan—ovarian cancer	0.00126	0.00227	CcSEcCtD
Hydralazine—Anorexia—Vinorelbine—ovarian cancer	0.00124	0.00225	CcSEcCtD
Hydralazine—Pancytopenia—Docetaxel—ovarian cancer	0.00124	0.00225	CcSEcCtD
Hydralazine—Hypoaesthesia—Paclitaxel—ovarian cancer	0.00123	0.00222	CcSEcCtD
Hydralazine—Neutropenia—Docetaxel—ovarian cancer	0.00122	0.00221	CcSEcCtD
Hydralazine—Hypotension—Vinorelbine—ovarian cancer	0.00122	0.0022	CcSEcCtD
Hydralazine—Pruritus—Chlorambucil—ovarian cancer	0.00121	0.00219	CcSEcCtD
Hydralazine—Urticaria—Topotecan—ovarian cancer	0.00121	0.00219	CcSEcCtD
Hydralazine—Body temperature increased—Topotecan—ovarian cancer	0.0012	0.00218	CcSEcCtD
Hydralazine—Lymphadenopathy—Epirubicin—ovarian cancer	0.0012	0.00216	CcSEcCtD
Hydralazine—Musculoskeletal discomfort—Vinorelbine—ovarian cancer	0.00119	0.00215	CcSEcCtD
Hydralazine—Urticaria—Melphalan—ovarian cancer	0.00118	0.00214	CcSEcCtD
Hydralazine—Weight decreased—Docetaxel—ovarian cancer	0.00118	0.00214	CcSEcCtD
Hydralazine—Diarrhoea—Chlorambucil—ovarian cancer	0.00117	0.00212	CcSEcCtD
Hydralazine—Paraesthesia—Vinorelbine—ovarian cancer	0.00117	0.00212	CcSEcCtD
Hydralazine—Hepatic function abnormal—Epirubicin—ovarian cancer	0.00117	0.00211	CcSEcCtD
Hydralazine—Dyspnoea—Vinorelbine—ovarian cancer	0.00116	0.0021	CcSEcCtD
Hydralazine—Flushing—Paclitaxel—ovarian cancer	0.00115	0.00207	CcSEcCtD
Hydralazine—Neuropathy peripheral—Docetaxel—ovarian cancer	0.00114	0.00207	CcSEcCtD
Hydralazine—Vascular purpura—Epirubicin—ovarian cancer	0.00114	0.00206	CcSEcCtD
Hydralazine—Jaundice—Docetaxel—ovarian cancer	0.00114	0.00205	CcSEcCtD
Hydralazine—Decreased appetite—Vinorelbine—ovarian cancer	0.00113	0.00205	CcSEcCtD
Hydralazine—Conjunctivitis—Docetaxel—ovarian cancer	0.00113	0.00205	CcSEcCtD
Hydralazine—Gastrointestinal disorder—Vinorelbine—ovarian cancer	0.00113	0.00204	CcSEcCtD
Hydralazine—Cardiac failure congestive—Epirubicin—ovarian cancer	0.00112	0.00203	CcSEcCtD
Hydralazine—Hypersensitivity—Topotecan—ovarian cancer	0.00112	0.00203	CcSEcCtD
Hydralazine—Constipation—Vinorelbine—ovarian cancer	0.00111	0.00202	CcSEcCtD
Hydralazine—Chills—Paclitaxel—ovarian cancer	0.00111	0.002	CcSEcCtD
Hydralazine—Lymphadenopathy—Doxorubicin—ovarian cancer	0.00111	0.002	CcSEcCtD
Hydralazine—Renal failure acute—Epirubicin—ovarian cancer	0.0011	0.002	CcSEcCtD
Hydralazine—Hypersensitivity—Melphalan—ovarian cancer	0.0011	0.00199	CcSEcCtD
Hydralazine—Vomiting—Chlorambucil—ovarian cancer	0.00109	0.00197	CcSEcCtD
Hydralazine—Agranulocytosis—Docetaxel—ovarian cancer	0.00109	0.00197	CcSEcCtD
Hydralazine—Hepatic function abnormal—Doxorubicin—ovarian cancer	0.00108	0.00195	CcSEcCtD
Hydralazine—Pruritus—Topotecan—ovarian cancer	0.00108	0.00195	CcSEcCtD
Hydralazine—Feeling abnormal—Vinorelbine—ovarian cancer	0.00107	0.00194	CcSEcCtD
Hydralazine—Purpura—Epirubicin—ovarian cancer	0.00106	0.00191	CcSEcCtD
Hydralazine—Pruritus—Melphalan—ovarian cancer	0.00106	0.00191	CcSEcCtD
Hydralazine—Vascular purpura—Doxorubicin—ovarian cancer	0.00105	0.00191	CcSEcCtD
Hydralazine—Hepatitis—Docetaxel—ovarian cancer	0.00105	0.00189	CcSEcCtD
Hydralazine—Cardiac failure—Epirubicin—ovarian cancer	0.00104	0.00189	CcSEcCtD
Hydralazine—Diarrhoea—Topotecan—ovarian cancer	0.00104	0.00189	CcSEcCtD
Hydralazine—Hypoaesthesia—Docetaxel—ovarian cancer	0.00104	0.00188	CcSEcCtD
Hydralazine—Cardiac failure congestive—Doxorubicin—ovarian cancer	0.00104	0.00188	CcSEcCtD
Hydralazine—Urticaria—Vinorelbine—ovarian cancer	0.00104	0.00187	CcSEcCtD
Hydralazine—Muscle spasms—Paclitaxel—ovarian cancer	0.00103	0.00187	CcSEcCtD
Hydralazine—Body temperature increased—Vinorelbine—ovarian cancer	0.00103	0.00186	CcSEcCtD
Hydralazine—Renal failure acute—Doxorubicin—ovarian cancer	0.00102	0.00185	CcSEcCtD
Hydralazine—Diarrhoea—Melphalan—ovarian cancer	0.00102	0.00185	CcSEcCtD
Hydralazine—Nausea—Chlorambucil—ovarian cancer	0.00102	0.00184	CcSEcCtD
Hydralazine—Dizziness—Topotecan—ovarian cancer	0.00101	0.00182	CcSEcCtD
Hydralazine—Tremor—Paclitaxel—ovarian cancer	0.00101	0.00182	CcSEcCtD
Hydralazine—Ill-defined disorder—Paclitaxel—ovarian cancer	0.000996	0.0018	CcSEcCtD
Hydralazine—Anaemia—Paclitaxel—ovarian cancer	0.000993	0.0018	CcSEcCtD
Hydralazine—Agitation—Paclitaxel—ovarian cancer	0.000987	0.00179	CcSEcCtD
Hydralazine—Purpura—Doxorubicin—ovarian cancer	0.000979	0.00177	CcSEcCtD
Hydralazine—Flushing—Docetaxel—ovarian cancer	0.000971	0.00176	CcSEcCtD
Hydralazine—Vomiting—Topotecan—ovarian cancer	0.000969	0.00175	CcSEcCtD
Hydralazine—Malaise—Paclitaxel—ovarian cancer	0.000969	0.00175	CcSEcCtD
Hydralazine—Cardiac failure—Doxorubicin—ovarian cancer	0.000967	0.00175	CcSEcCtD
Hydralazine—Leukopenia—Paclitaxel—ovarian cancer	0.000961	0.00174	CcSEcCtD
Hydralazine—Rash—Topotecan—ovarian cancer	0.000961	0.00174	CcSEcCtD
Hydralazine—Hypersensitivity—Vinorelbine—ovarian cancer	0.00096	0.00174	CcSEcCtD
Hydralazine—Dermatitis—Topotecan—ovarian cancer	0.00096	0.00174	CcSEcCtD
Hydralazine—Headache—Topotecan—ovarian cancer	0.000954	0.00173	CcSEcCtD
Hydralazine—Palpitations—Paclitaxel—ovarian cancer	0.000949	0.00172	CcSEcCtD
Hydralazine—Vomiting—Melphalan—ovarian cancer	0.000948	0.00172	CcSEcCtD
Hydralazine—Rash—Melphalan—ovarian cancer	0.00094	0.0017	CcSEcCtD
Hydralazine—Dermatitis—Melphalan—ovarian cancer	0.00094	0.0017	CcSEcCtD
Hydralazine—Chills—Docetaxel—ovarian cancer	0.000938	0.0017	CcSEcCtD
Hydralazine—Pruritus—Vinorelbine—ovarian cancer	0.000922	0.00167	CcSEcCtD
Hydralazine—Arthralgia—Paclitaxel—ovarian cancer	0.000914	0.00165	CcSEcCtD
Hydralazine—Myalgia—Paclitaxel—ovarian cancer	0.000914	0.00165	CcSEcCtD
Hydralazine—Anxiety—Paclitaxel—ovarian cancer	0.000911	0.00165	CcSEcCtD
Hydralazine—Nausea—Topotecan—ovarian cancer	0.000905	0.00164	CcSEcCtD
Hydralazine—Discomfort—Paclitaxel—ovarian cancer	0.000903	0.00163	CcSEcCtD
Hydralazine—Diarrhoea—Vinorelbine—ovarian cancer	0.000892	0.00161	CcSEcCtD
Hydralazine—Nausea—Melphalan—ovarian cancer	0.000886	0.0016	CcSEcCtD
Hydralazine—Oedema—Paclitaxel—ovarian cancer	0.000877	0.00159	CcSEcCtD
Hydralazine—Muscle spasms—Docetaxel—ovarian cancer	0.000875	0.00158	CcSEcCtD
Hydralazine—Eosinophilia—Epirubicin—ovarian cancer	0.000872	0.00158	CcSEcCtD
Hydralazine—Dizziness—Vinorelbine—ovarian cancer	0.000862	0.00156	CcSEcCtD
Hydralazine—Angina pectoris—Epirubicin—ovarian cancer	0.000858	0.00155	CcSEcCtD
Hydralazine—Thrombocytopenia—Paclitaxel—ovarian cancer	0.000858	0.00155	CcSEcCtD
Hydralazine—Tachycardia—Paclitaxel—ovarian cancer	0.000855	0.00155	CcSEcCtD
Hydralazine—Anaemia—Docetaxel—ovarian cancer	0.000841	0.00152	CcSEcCtD
Hydralazine—Pancytopenia—Epirubicin—ovarian cancer	0.000837	0.00151	CcSEcCtD
Hydralazine—Anorexia—Paclitaxel—ovarian cancer	0.000836	0.00151	CcSEcCtD
Hydralazine—Vomiting—Vinorelbine—ovarian cancer	0.000829	0.0015	CcSEcCtD
Hydralazine—Neutropenia—Epirubicin—ovarian cancer	0.000824	0.00149	CcSEcCtD
Hydralazine—Dysuria—Epirubicin—ovarian cancer	0.000824	0.00149	CcSEcCtD
Hydralazine—Rash—Vinorelbine—ovarian cancer	0.000822	0.00149	CcSEcCtD
Hydralazine—Dermatitis—Vinorelbine—ovarian cancer	0.000821	0.00149	CcSEcCtD
Hydralazine—Hypotension—Paclitaxel—ovarian cancer	0.000819	0.00148	CcSEcCtD
Hydralazine—Headache—Vinorelbine—ovarian cancer	0.000816	0.00148	CcSEcCtD
Hydralazine—Leukopenia—Docetaxel—ovarian cancer	0.000815	0.00147	CcSEcCtD
Hydralazine—Eosinophilia—Doxorubicin—ovarian cancer	0.000807	0.00146	CcSEcCtD
Hydralazine—Palpitations—Docetaxel—ovarian cancer	0.000804	0.00146	CcSEcCtD
Hydralazine—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000799	0.00145	CcSEcCtD
Hydralazine—Weight decreased—Epirubicin—ovarian cancer	0.000797	0.00144	CcSEcCtD
Hydralazine—Angina pectoris—Doxorubicin—ovarian cancer	0.000794	0.00144	CcSEcCtD
Hydralazine—Paraesthesia—Paclitaxel—ovarian cancer	0.000787	0.00142	CcSEcCtD
Hydralazine—Dyspnoea—Paclitaxel—ovarian cancer	0.000781	0.00141	CcSEcCtD
Hydralazine—Myalgia—Docetaxel—ovarian cancer	0.000775	0.0014	CcSEcCtD
Hydralazine—Arthralgia—Docetaxel—ovarian cancer	0.000775	0.0014	CcSEcCtD
Hydralazine—Pancytopenia—Doxorubicin—ovarian cancer	0.000774	0.0014	CcSEcCtD
Hydralazine—Nausea—Vinorelbine—ovarian cancer	0.000774	0.0014	CcSEcCtD
Hydralazine—Dyspepsia—Paclitaxel—ovarian cancer	0.000772	0.0014	CcSEcCtD
Hydralazine—Neuropathy peripheral—Epirubicin—ovarian cancer	0.00077	0.00139	CcSEcCtD
Hydralazine—Jaundice—Epirubicin—ovarian cancer	0.000766	0.00139	CcSEcCtD
Hydralazine—Conjunctivitis—Epirubicin—ovarian cancer	0.000764	0.00138	CcSEcCtD
Hydralazine—Dysuria—Doxorubicin—ovarian cancer	0.000762	0.00138	CcSEcCtD
Hydralazine—Neutropenia—Doxorubicin—ovarian cancer	0.000762	0.00138	CcSEcCtD
Hydralazine—Decreased appetite—Paclitaxel—ovarian cancer	0.000762	0.00138	CcSEcCtD
Hydralazine—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000757	0.00137	CcSEcCtD
Hydralazine—Constipation—Paclitaxel—ovarian cancer	0.00075	0.00136	CcSEcCtD
Hydralazine—Haematuria—Epirubicin—ovarian cancer	0.000749	0.00136	CcSEcCtD
Hydralazine—Oedema—Docetaxel—ovarian cancer	0.000743	0.00134	CcSEcCtD
Hydralazine—Weight decreased—Doxorubicin—ovarian cancer	0.000738	0.00133	CcSEcCtD
Hydralazine—Agranulocytosis—Epirubicin—ovarian cancer	0.000733	0.00133	CcSEcCtD
Hydralazine—Thrombocytopenia—Docetaxel—ovarian cancer	0.000727	0.00132	CcSEcCtD
Hydralazine—Tachycardia—Docetaxel—ovarian cancer	0.000725	0.00131	CcSEcCtD
Hydralazine—Feeling abnormal—Paclitaxel—ovarian cancer	0.000722	0.00131	CcSEcCtD
Hydralazine—Neuropathy peripheral—Doxorubicin—ovarian cancer	0.000713	0.00129	CcSEcCtD
Hydralazine—Jaundice—Doxorubicin—ovarian cancer	0.000709	0.00128	CcSEcCtD
Hydralazine—Anorexia—Docetaxel—ovarian cancer	0.000708	0.00128	CcSEcCtD
Hydralazine—Conjunctivitis—Doxorubicin—ovarian cancer	0.000707	0.00128	CcSEcCtD
Hydralazine—Hepatitis—Epirubicin—ovarian cancer	0.000705	0.00128	CcSEcCtD
Hydralazine—Hypoaesthesia—Epirubicin—ovarian cancer	0.000702	0.00127	CcSEcCtD
Hydralazine—Urticaria—Paclitaxel—ovarian cancer	0.000696	0.00126	CcSEcCtD
Hydralazine—Hypotension—Docetaxel—ovarian cancer	0.000694	0.00126	CcSEcCtD
Hydralazine—Haematuria—Doxorubicin—ovarian cancer	0.000693	0.00125	CcSEcCtD
Hydralazine—Body temperature increased—Paclitaxel—ovarian cancer	0.000693	0.00125	CcSEcCtD
Hydralazine—Agranulocytosis—Doxorubicin—ovarian cancer	0.000678	0.00123	CcSEcCtD
Hydralazine—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000677	0.00122	CcSEcCtD
Hydralazine—Paraesthesia—Docetaxel—ovarian cancer	0.000667	0.00121	CcSEcCtD
Hydralazine—Dyspnoea—Docetaxel—ovarian cancer	0.000662	0.0012	CcSEcCtD
Hydralazine—Flushing—Epirubicin—ovarian cancer	0.000655	0.00118	CcSEcCtD
Hydralazine—Dyspepsia—Docetaxel—ovarian cancer	0.000654	0.00118	CcSEcCtD
Hydralazine—Hepatitis—Doxorubicin—ovarian cancer	0.000653	0.00118	CcSEcCtD
Hydralazine—Hypoaesthesia—Doxorubicin—ovarian cancer	0.000649	0.00118	CcSEcCtD
Hydralazine—Decreased appetite—Docetaxel—ovarian cancer	0.000646	0.00117	CcSEcCtD
Hydralazine—Hypersensitivity—Paclitaxel—ovarian cancer	0.000646	0.00117	CcSEcCtD
Hydralazine—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000641	0.00116	CcSEcCtD
Hydralazine—Constipation—Docetaxel—ovarian cancer	0.000635	0.00115	CcSEcCtD
Hydralazine—Chills—Epirubicin—ovarian cancer	0.000633	0.00115	CcSEcCtD
Hydralazine—Pruritus—Paclitaxel—ovarian cancer	0.00062	0.00112	CcSEcCtD
Hydralazine—Feeling abnormal—Docetaxel—ovarian cancer	0.000612	0.00111	CcSEcCtD
Hydralazine—Flushing—Doxorubicin—ovarian cancer	0.000606	0.0011	CcSEcCtD
Hydralazine—Diarrhoea—Paclitaxel—ovarian cancer	0.0006	0.00109	CcSEcCtD
Hydralazine—Muscle spasms—Epirubicin—ovarian cancer	0.00059	0.00107	CcSEcCtD
Hydralazine—Body temperature increased—Docetaxel—ovarian cancer	0.000587	0.00106	CcSEcCtD
Hydralazine—Chills—Doxorubicin—ovarian cancer	0.000586	0.00106	CcSEcCtD
Hydralazine—Dizziness—Paclitaxel—ovarian cancer	0.00058	0.00105	CcSEcCtD
Hydralazine—Ill-defined disorder—Epirubicin—ovarian cancer	0.00057	0.00103	CcSEcCtD
Hydralazine—Anaemia—Epirubicin—ovarian cancer	0.000568	0.00103	CcSEcCtD
Hydralazine—Agitation—Epirubicin—ovarian cancer	0.000564	0.00102	CcSEcCtD
Hydralazine—Vomiting—Paclitaxel—ovarian cancer	0.000557	0.00101	CcSEcCtD
Hydralazine—Malaise—Epirubicin—ovarian cancer	0.000554	0.001	CcSEcCtD
Hydralazine—Rash—Paclitaxel—ovarian cancer	0.000553	0.001	CcSEcCtD
Hydralazine—Dermatitis—Paclitaxel—ovarian cancer	0.000552	0.000999	CcSEcCtD
Hydralazine—Leukopenia—Epirubicin—ovarian cancer	0.00055	0.000995	CcSEcCtD
Hydralazine—Headache—Paclitaxel—ovarian cancer	0.000549	0.000994	CcSEcCtD
Hydralazine—Hypersensitivity—Docetaxel—ovarian cancer	0.000547	0.00099	CcSEcCtD
Hydralazine—Muscle spasms—Doxorubicin—ovarian cancer	0.000546	0.000988	CcSEcCtD
Hydralazine—Palpitations—Epirubicin—ovarian cancer	0.000543	0.000982	CcSEcCtD
Hydralazine—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000527	0.000954	CcSEcCtD
Hydralazine—Pruritus—Docetaxel—ovarian cancer	0.000526	0.000951	CcSEcCtD
Hydralazine—Anaemia—Doxorubicin—ovarian cancer	0.000525	0.00095	CcSEcCtD
Hydralazine—Arthralgia—Epirubicin—ovarian cancer	0.000523	0.000946	CcSEcCtD
Hydralazine—Myalgia—Epirubicin—ovarian cancer	0.000523	0.000946	CcSEcCtD
Hydralazine—Agitation—Doxorubicin—ovarian cancer	0.000522	0.000945	CcSEcCtD
Hydralazine—Anxiety—Epirubicin—ovarian cancer	0.000521	0.000943	CcSEcCtD
Hydralazine—Nausea—Paclitaxel—ovarian cancer	0.000521	0.000942	CcSEcCtD
Hydralazine—Discomfort—Epirubicin—ovarian cancer	0.000516	0.000935	CcSEcCtD
Hydralazine—Malaise—Doxorubicin—ovarian cancer	0.000512	0.000927	CcSEcCtD
Hydralazine—Leukopenia—Doxorubicin—ovarian cancer	0.000509	0.00092	CcSEcCtD
Hydralazine—Diarrhoea—Docetaxel—ovarian cancer	0.000508	0.00092	CcSEcCtD
Hydralazine—Palpitations—Doxorubicin—ovarian cancer	0.000502	0.000908	CcSEcCtD
Hydralazine—Oedema—Epirubicin—ovarian cancer	0.000501	0.000907	CcSEcCtD
Hydralazine—Dizziness—Docetaxel—ovarian cancer	0.000491	0.000889	CcSEcCtD
Hydralazine—Thrombocytopenia—Epirubicin—ovarian cancer	0.000491	0.000888	CcSEcCtD
Hydralazine—Tachycardia—Epirubicin—ovarian cancer	0.000489	0.000885	CcSEcCtD
Hydralazine—Myalgia—Doxorubicin—ovarian cancer	0.000484	0.000875	CcSEcCtD
Hydralazine—Arthralgia—Doxorubicin—ovarian cancer	0.000484	0.000875	CcSEcCtD
Hydralazine—Anxiety—Doxorubicin—ovarian cancer	0.000482	0.000872	CcSEcCtD
Hydralazine—Discomfort—Doxorubicin—ovarian cancer	0.000478	0.000865	CcSEcCtD
Hydralazine—Anorexia—Epirubicin—ovarian cancer	0.000478	0.000864	CcSEcCtD
Hydralazine—Vomiting—Docetaxel—ovarian cancer	0.000472	0.000855	CcSEcCtD
Hydralazine—Rash—Docetaxel—ovarian cancer	0.000468	0.000848	CcSEcCtD
Hydralazine—Hypotension—Epirubicin—ovarian cancer	0.000468	0.000847	CcSEcCtD
Hydralazine—Dermatitis—Docetaxel—ovarian cancer	0.000468	0.000847	CcSEcCtD
Hydralazine—Headache—Docetaxel—ovarian cancer	0.000465	0.000842	CcSEcCtD
Hydralazine—Oedema—Doxorubicin—ovarian cancer	0.000464	0.000839	CcSEcCtD
Hydralazine—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000457	0.000826	CcSEcCtD
Hydralazine—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000454	0.000821	CcSEcCtD
Hydralazine—Tachycardia—Doxorubicin—ovarian cancer	0.000453	0.000819	CcSEcCtD
Hydralazine—Paraesthesia—Epirubicin—ovarian cancer	0.00045	0.000814	CcSEcCtD
Hydralazine—Dyspnoea—Epirubicin—ovarian cancer	0.000447	0.000808	CcSEcCtD
Hydralazine—Anorexia—Doxorubicin—ovarian cancer	0.000442	0.0008	CcSEcCtD
Hydralazine—Nausea—Docetaxel—ovarian cancer	0.000441	0.000799	CcSEcCtD
Hydralazine—Dyspepsia—Epirubicin—ovarian cancer	0.000441	0.000798	CcSEcCtD
Hydralazine—Decreased appetite—Epirubicin—ovarian cancer	0.000436	0.000788	CcSEcCtD
Hydralazine—Hypotension—Doxorubicin—ovarian cancer	0.000433	0.000784	CcSEcCtD
Hydralazine—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000433	0.000783	CcSEcCtD
Hydralazine—Constipation—Epirubicin—ovarian cancer	0.000429	0.000775	CcSEcCtD
Hydralazine—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000422	0.000764	CcSEcCtD
Hydralazine—Paraesthesia—Doxorubicin—ovarian cancer	0.000416	0.000753	CcSEcCtD
Hydralazine—Dyspnoea—Doxorubicin—ovarian cancer	0.000413	0.000748	CcSEcCtD
Hydralazine—Feeling abnormal—Epirubicin—ovarian cancer	0.000413	0.000747	CcSEcCtD
Hydralazine—Dyspepsia—Doxorubicin—ovarian cancer	0.000408	0.000739	CcSEcCtD
Hydralazine—Decreased appetite—Doxorubicin—ovarian cancer	0.000403	0.000729	CcSEcCtD
Hydralazine—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.0004	0.000724	CcSEcCtD
Hydralazine—Urticaria—Epirubicin—ovarian cancer	0.000398	0.00072	CcSEcCtD
Hydralazine—Constipation—Doxorubicin—ovarian cancer	0.000397	0.000717	CcSEcCtD
Hydralazine—Body temperature increased—Epirubicin—ovarian cancer	0.000396	0.000717	CcSEcCtD
Hydralazine—Feeling abnormal—Doxorubicin—ovarian cancer	0.000382	0.000691	CcSEcCtD
Hydralazine—Hypersensitivity—Epirubicin—ovarian cancer	0.000369	0.000668	CcSEcCtD
Hydralazine—Urticaria—Doxorubicin—ovarian cancer	0.000368	0.000667	CcSEcCtD
Hydralazine—Body temperature increased—Doxorubicin—ovarian cancer	0.000367	0.000663	CcSEcCtD
Hydralazine—Pruritus—Epirubicin—ovarian cancer	0.000355	0.000642	CcSEcCtD
Hydralazine—Diarrhoea—Epirubicin—ovarian cancer	0.000343	0.00062	CcSEcCtD
Hydralazine—Hypersensitivity—Doxorubicin—ovarian cancer	0.000342	0.000618	CcSEcCtD
Hydralazine—Dizziness—Epirubicin—ovarian cancer	0.000331	0.0006	CcSEcCtD
Hydralazine—Pruritus—Doxorubicin—ovarian cancer	0.000328	0.000594	CcSEcCtD
Hydralazine—Vomiting—Epirubicin—ovarian cancer	0.000319	0.000577	CcSEcCtD
Hydralazine—Diarrhoea—Doxorubicin—ovarian cancer	0.000317	0.000574	CcSEcCtD
Hydralazine—Rash—Epirubicin—ovarian cancer	0.000316	0.000572	CcSEcCtD
Hydralazine—Dermatitis—Epirubicin—ovarian cancer	0.000316	0.000571	CcSEcCtD
Hydralazine—Headache—Epirubicin—ovarian cancer	0.000314	0.000568	CcSEcCtD
Hydralazine—Dizziness—Doxorubicin—ovarian cancer	0.000307	0.000555	CcSEcCtD
Hydralazine—Nausea—Epirubicin—ovarian cancer	0.000298	0.000539	CcSEcCtD
Hydralazine—Vomiting—Doxorubicin—ovarian cancer	0.000295	0.000533	CcSEcCtD
Hydralazine—Rash—Doxorubicin—ovarian cancer	0.000292	0.000529	CcSEcCtD
Hydralazine—Dermatitis—Doxorubicin—ovarian cancer	0.000292	0.000529	CcSEcCtD
Hydralazine—Headache—Doxorubicin—ovarian cancer	0.00029	0.000526	CcSEcCtD
Hydralazine—Nausea—Doxorubicin—ovarian cancer	0.000275	0.000498	CcSEcCtD
